Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aptinyx Inc. is a biopharmaceutical company.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
Interius BioTherapeutics is a biotechnology company that delivers genetic medicines for patients.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Serán Bioscience is a contract development and manufacturing organization.
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
CereVasc is a medical device company focused on improving the treatment of patients with hydrocephalus.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Bain Capital Life Sciences has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Bain Capital Life Sciences's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 13 different industry categories.
Among tracked funding rounds, Kailera Therapeutics received $600.0M in a Series B round. Bain Capital Life Sciences's total known invested capital is $9.0B.
Bain Capital Life Sciences's average investment size is $163.2M across its portfolio of 57 companies.
Recent Bain Capital Life Sciences portfolio additions include Aptinyx, Replimune Group, Nuvalent, Jnana Therapeutics, X4 Pharmaceuticals. These companies were founded in 2020 or later.